BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 4928082)

  • 21. Immunosuppression versus immunity in syngeneic and allogeneic tumours.
    Vlachov K; Nouza K
    Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871
    [No Abstract]   [Full Text] [Related]  

  • 22. Transfer of immunity against long surviving rat skin xenografts by antilymphocyte serum treated Syrian hamsters.
    Shaffer CF
    Nature; 1969 Sep; 223(5213):1375-7. PubMed ID: 4897377
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of the development of primary antitoxic immunity by heterologous antilymphocyte serum.
    Réthy L; Hegedüs L
    Acta Microbiol Acad Sci Hung; 1969; 16(3):203-9. PubMed ID: 4908388
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological enhancement.
    Russell PS
    Transplant Proc; 1971 Mar; 3(1):960-6. PubMed ID: 4941150
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunosuppressive effects of antilymphocyte serum in complement-deficient mice: evidence that immune cytolysis is not essential for ALS activity.
    Barth RF; Carroll GF
    J Immunol; 1970 Feb; 104(2):522-4. PubMed ID: 4904885
    [No Abstract]   [Full Text] [Related]  

  • 26. Heterologous antilymphocyte serum: differential effect on antigen-sensitive and antibody-producing cells.
    Möller G; Zukoski CF
    Surgery; 1968 Jul; 64(1):39-47. PubMed ID: 5658739
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antilymphocytic serum].
    Policlinico Prat; 1968 Jul; 75(27):883-6. PubMed ID: 4174248
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppressive effects of anti-lymphocyte serum in complement deficient mice. II. Evidence that activity is mediated by C3 independent antibodies.
    Barth RF; Singla O; Ward PA
    J Immunol; 1974 Feb; 112(2):858-61. PubMed ID: 4205210
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiac and skin heterograft rejection: suppression with antilymphocyte serum.
    Donawick WJ; Shaffer CF; Dodd DC; Buchanan JW; Fregin GF
    Transplant Proc; 1971 Mar; 3(1):551-3. PubMed ID: 4937937
    [No Abstract]   [Full Text] [Related]  

  • 30. Passive enhancement of skin heterografts.
    Jeekel J; Westbroek DL
    Transplant Proc; 1971 Mar; 3(1):714-6. PubMed ID: 4937964
    [No Abstract]   [Full Text] [Related]  

  • 31. Cross-species transplantation in embryonic and neonatal animals.
    Steinmuller D
    Transplant Proc; 1970 Dec; 2(4):438-45. PubMed ID: 4939692
    [No Abstract]   [Full Text] [Related]  

  • 32. The Cape Western baboon in organ allotransplantation.
    Murphy GP; Brede HD; Cohen E; Grace JT
    Transplant Proc; 1970 Dec; 2(4):546-9. PubMed ID: 5000235
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative studies on tissue transplantation immunity. IX. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar P
    Proc R Soc Lond B Biol Sci; 1969 Jul; 173(1033):447-73. PubMed ID: 4389455
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppressive action of L-asparaginase in mice.
    Nelson SD; Lee MB; Bridges JM
    Br J Haematol; 1969 Dec; 17(6):610. PubMed ID: 4901993
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppression of the donor in order to affect chronic secondary disease of the recipient.
    Thierfelder S; Werner J; Götze D
    Blut; 1970; 21(6):384-8. PubMed ID: 4923980
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of heterologous antilymphocytic serum on peripheral leukocytes and on the lymphoid organs of BALB-c mice].
    Cerulli L; Cimmino PT; Garaci E
    Riv Biol; 1969; 62(1):75-98. PubMed ID: 4893965
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro assay for antilymphocyte serum.
    Bach JF
    Fed Proc; 1970; 29(1):120-2. PubMed ID: 4904618
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppressive potency of antiserum to thymus glands prepared with ribosomal fraction.
    Nagaya H; McKenzie WN; Kilburn KH; Sieker HO
    J Immunol; 1970 Feb; 104(2):511-3. PubMed ID: 4904884
    [No Abstract]   [Full Text] [Related]  

  • 40. A new in vitro assay for immunosuppressive potency of antilymphocyte serum.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1972 Dec; 4(4):481-5. PubMed ID: 4566791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.